26
chapotraphouse
13548 readers
1 users here now
Banned? DM Wmill to appeal.
No anti-nautilism posts. See: Eco-fascism Primer
Gossip posts go in c/gossip. Don't post low-hanging fruit here after it gets removed from c/gossip
founded 3 years ago
MODERATORS
29
30
31
1
In Trans Star Wars, they slice open Blahaj and sleep inside his cotton shork insides to stay warm
(hexbear.net)
32
33
Then again, the As Seen on TV government for the US seems right.
34
Can you believe it sir, some beta male on X called me, ME, a Soyjak! 
[drinks vial of baby's blood]
hooah that's the stuff, y'know I don't drink, nuh-uh not for me, but this adrenaline stuff hits hard 
Did you hear what I said sir, me, a Soyjak
Who the fuck is 'Soy Jack' Elon you keep trying to introduce me to these bozos you keep around, I swear to god
No, sir, it's a meme from 4chan
I told you Elon, I don't care what Four Chan has to say about this shit, stop talking about internet nerd shit
I'm sorry sir. [yells at intern bringing his adrenochrome baby blood cocktail]
38
42
44
45
1
46
1
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
(www.businesswire.com)
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug (IND) application, ARCT-2304, a self-amplifying mRNA (sa-mRNA) vaccine candidate for active immunization to prevent pandemic influenza disease caused by H5N1 virus. The clinical study is funded by Biomedical Advanced Research and Development Authority (BARDA) and designed to enroll approximately 200 healthy adults in the United States.
The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.
"Arcturus is actively engaged with the U.S. government to prepare for the next pandemic, and clearance to proceed into the clinic with our STARR® self-amplifying mRNA technology is a key step in this important process,” said Joseph Payne, President & CEO of Arcturus Therapeutics. “The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.”
About ARCT-2304
ARCT-2304 is a sa-mRNA vaccine candidate formulated within a lipid nanoparticle (LNP). The sa-mRNA vaccine candidate is designed to make many copies of mRNA within the host cell after intramuscular injection to achieve enhanced expression of haemagglutinin (HA) and neuraminidase (NA) antigens, thereby enabling lower doses than conventional mRNA vaccines. Utilizing a mRNA-based platform for pandemic influenza vaccine development offers further options for meeting domestic vaccine manufacturing surge capacity goals. The technology may make vaccines available much sooner than egg- and cell-based technologies. The lyophilized vaccine formulation is stable in refrigerators, thereby simplifying cold-chain storage and reducing distribution risks.
47
48
49
1
Effortpost: Even the "Winners" of Bidenomics Are Angry. They’re Right to Be!
(serlava.substack.com)
50
1
"Southern Gaza Under the Weight of Famine: Children and Families Facing Death from Hunger"
(hexbear.net)
In southern Gaza, people are living in indescribable suffering. Hunger threatens the lives of children and families, amid a severe shortage of food and resources. Every passing day intensifies the tragedy, leaving them facing death from hunger. They are in urgent need of support before it’s too late.
https://gofund.me/1222af19
